CN113337587B - Rapid sensitive detection method for NOTCH2NLC gene GGC repetitive sequence and application thereof - Google Patents
Rapid sensitive detection method for NOTCH2NLC gene GGC repetitive sequence and application thereof Download PDFInfo
- Publication number
- CN113337587B CN113337587B CN202110850961.1A CN202110850961A CN113337587B CN 113337587 B CN113337587 B CN 113337587B CN 202110850961 A CN202110850961 A CN 202110850961A CN 113337587 B CN113337587 B CN 113337587B
- Authority
- CN
- China
- Prior art keywords
- ggc
- notch2nlc
- gene
- primer
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention relates to the field of medicine, in particular to a rapid sensitive detection method of a NOTCH2NLC gene GGC repetitive sequence and application thereof. Firstly, a primer composition for detecting a GGC repetitive sequence of a NOTCH2NLC gene is disclosed, which comprises the following components: the nucleotide sequence is shown as SEQ ID NO:1, and the nucleotide sequence of the upstream primer is shown as SEQ ID NO:2, the nucleotide sequence of the downstream primer is shown as SEQ ID NO:3, or a third primer. The invention discloses a novel primer composition for detecting a sample with high GGC repetition number, optimizes a PCR detection program, is more sensitive to the detection of the sample with high GGC repetition number, can accurately quantify and complete the detection more quickly, shortens the PCR time from 10 hours to within 2 hours, effectively reduces the workload of operators and reduces the detection cost.
Description
Technical Field
The invention relates to the field of medicine, in particular to a rapid sensitive detection method of a NOTCH2NLC gene GGC repetitive sequence and application thereof.
Background
Neuronal nuclear inclusion disease (NIID) is a very rare disease, and early case reports are common in European and American populations, and are common in children and teenagers, and later in Asian adults. The clinical manifestations of NIID are complex and diverse and include dementia, ataxia, behavioral abnormalities, tremors, epilepsy, and the like. The abnormal repeated amplification of 5' UTR GGC in NOTCH2NLC gene is related to NIID in 2019, and is subsequently and sequentially related to various neurodegenerative diseases such as Alzheimer disease, frontotemporal dementia and the like [1] 。
Currently, the diagnosis of NIID mainly involves classical P62 and UB staining positive eosinophilic endonuclears and NOTCH2NLC gene detection, and diagnosis is not difficult. Based on PCR amplification NOTCH2NLC gene, the resolution ratio of capillary electrophoresis detection amplification fragment is higher than that of the traditional agarose gel electrophoresis, but because the CG proportion of the amplification fragment is too high and the difficulty is increased along with the number of repetition times, the design of most PCR primers is difficult, because a PCR reaction system cannot be adjusted to the optimal condition, the detection result can be misjudged, and meanwhile, during PCR, the detection result is misjudgedThe time is more than 10 hours [2] . Therefore, the invention of a novel rapid sensitive detection method for the GGC repetitive sequence of the NOTCH2NLC gene is in need.
Reference:
1.Tian,Y.,et al.,Expansion of Human-Specific GGC Repeat in Neuronal Intranuclear Inclusion Disease-Related Disorders.Am J Hum Genet,2019.105(1):p.166-176.
2.Sone,J.,et al.,Long-read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease.Nat Genet,2019.51(8):p.1215-1221.
disclosure of Invention
The invention aims to disclose a novel detection method, which is also called triple Repeat Primed PCR (TP-PCR) by a three-primer PCR method. The TP-PCR method is different from the traditional PCR amplification method, and 3 primers are added in the reaction. The TP-PCR method of the NOTCH2NLC gene adds a GGC sequence primer on the basis of general PCR amplification, is more sensitive to the detection of a sample with high GGC repetition number, can accurately quantify and complete the detection more quickly, shortens the PCR time from 10 hours to within 2 hours (1 hour and 40 minutes), effectively reduces the workload of operators and reduces the detection cost.
Specifically, the technical scheme of the invention is as follows:
the invention discloses a primer composition for detecting a GGC repetitive sequence of a NOTCH2NLC gene, which comprises the following components: the nucleotide sequence is shown as SEQ ID NO:1, and the nucleotide sequence is shown as SEQ ID NO:2, the nucleotide sequence of the downstream primer is shown as SEQ ID NO:3, or a third primer.
In a second aspect, the invention discloses an amplification reaction system for amplifying a GGC repeat sequence of a NOTCH2NLC gene, wherein the amplification reaction system comprises the primer composition.
The third aspect of the invention discloses a kit for rapidly detecting a GGC repetitive sequence of a NOTCH2NLC gene, which comprises the primer composition or the amplification reaction system.
The fourth aspect of the invention discloses a method for rapidly detecting a NOTCH2NLC gene GGC repetitive sequence by using the amplification reaction system or the kit, wherein the PCR reaction program for amplifying the NOTCH2NLC gene GGC repetitive sequence is as follows:
reacting for 10min at the temperature of 98 ℃; followed by reaction at 98 ℃ for 30sec, at 66 ℃ for 1min (0.5 ℃ per cycle), and at 68 ℃ for 1min for a total of 20 cycles; then carrying out reaction for 30sec at 98 ℃, 30sec at 56 ℃ and 1min at 68 ℃ for 15 cycles in total; finally 68 ℃ for 10 minutes. The adjustment for all cycling steps was 0.5 ℃/sec.
Preferably, the method comprises:
obtaining genome DNA of a sample to be detected;
amplifying the NOTCH2NLC gene by using the amplification reaction system or the kit through PCR;
and detecting the repeated sequence GGC of the NOTCH2NLC gene in the obtained amplification product.
Preferably, the repeated sequence GGC of the NOTCH2NLC gene in the amplification product is detected by capillary electrophoresis.
The fifth aspect of the invention discloses the application of the primer composition, the amplification reaction system, the kit or the method in the medical field.
Preferably, the application is the application of the primer composition, the amplification reaction system, the kit or the method in auxiliary prediction and/or diagnosis of the neuron endonucleosome diseases.
On the basis of the common general knowledge in the field, the above preferred conditions can be combined arbitrarily without departing from the concept and the protection scope of the invention.
Compared with the prior art, the invention has the following remarkable advantages and effects:
the invention discloses a novel primer composition for detecting a sample with high GGC repetition number, optimizes a PCR detection program, is more sensitive to the detection of the sample with high GGC repetition number, can accurately quantify, can finish the detection more quickly, shortens the PCR time from 10 hours to within 2 hours, effectively reduces the workload of operators and reduces the detection cost.
Drawings
FIG. 1 is a schematic diagram showing the design of a primer GGC for 5' UTR of NOTCH2NLC gene;
FIG. 2 is a schematic diagram showing the comparison of capillary electrophoresis effects of DNA samples of positive patients detected by different primers;
FIG. 3 is a diagram showing the comparison of capillary electrophoresis effect sensitivity of DNA samples of positive patients detected by different primers;
FIG. 4 is a schematic diagram showing the comparison of capillary electrophoresis effects under different PCR detection procedures;
FIG. 5 is a schematic diagram showing the electrophoresis effect of capillary vessels in 10 positive patients;
FIG. 6 is a diagram showing the effect of capillary electrophoresis in 10 negative cases.
Detailed Description
The technical solutions of the present invention are described in detail below with reference to the drawings and embodiments, but the present invention is not limited to the scope of the embodiments.
The experimental methods without specifying specific conditions in the following examples were selected according to the conventional methods and conditions, or according to the commercial instructions. The reagents and starting materials used in the present invention are commercially available.
Example 1
The embodiment discloses a method for rapidly detecting a GGC repetitive sequence of a NOTCH2NLC gene, which specifically comprises the following steps:
1. obtaining genome DNA of a sample to be detected;
2. amplifying a NOTCH2NLC gene by using an amplification reaction system;
3. and detecting the repeated sequence GGC of the NOTCH2NLC gene in the obtained amplification product.
Wherein the amplification reaction system comprises a primer composition, the primer composition consists of an upstream primer, a downstream primer and a third primer of a non-human gene sequence, and is shown in figure 1, and the specific sequence is shown in table 1.
TABLE 1
The amplification reaction system is shown in Table 2 below.
TABLE 2
The cited document 2 procedure, i.e. the amplification procedure, is:
reacting for 10min at the temperature of 98 ℃; followed by reaction at 98 ℃ for 30sec, at 66 ℃ for 1min (0.5 ℃ per cycle), and at 68 ℃ for 8min for a total of 16 cycles; then carrying out reaction for 30sec at 98 ℃, reaction for 1min at 58 ℃ and reaction for 8min at 68 ℃ for 29 cycles in total; finally 68 ℃ for 10 minutes, all cycle steps were adjusted to 0.5 ℃/sec.
The results of experiments using the primers in the literature as comparative examples and the primers in Table 1 as tests are shown in FIG. 2.
Example 2
The method of this example is different from example 1 only in that the amplification procedure is as follows:
reacting for 10min at the temperature of 98 ℃; followed by reaction at 98 ℃ for 30sec, at 66 ℃ for 1min (0.5 ℃ per cycle), and at 68 ℃ for 1min for a total of 20 cycles; then carrying out reaction for 30sec at 98 ℃, 30sec at 56 ℃ and 1min at 68 ℃ for 15 cycles in total; finally 68 ℃ for 10 minutes. The adjustment of all the circulation steps is 0.5 ℃/s, and the new program is obtained.
It was found that the novel procedure of the inventive primers (shown in table 1 above) well solved the PCR amplification of the 5'utr GGC aberrant repeat in the NOTCH2NLC gene, and as shown in fig. 4, the procedure of 1 hour and 40 minutes was found to complete the PCR amplification of the 5' utr GGC aberrant repeat in the NOTCH2NLC gene.
Example 3
In this example, the sensitivity of the inventive primers to aberrant repeat amplification of 5' UTR GGC in the NOTCH2NLC gene of a different template positive control was investigated, and the results are shown in FIG. 3. After the DNA sample (5 ng-300 ng) of a positive control patient is subjected to PCR amplification through a literature primer and the innovative primer, the capillary electrophoresis effect comparison shows that the innovative primer is more sensitive, and a positive signal can be detected after 5 ng.
Example 4
In this example, 20 samples, 10 positive patients and 10 negative patients, were tested by using the innovative primer and amplification system in example 1 and the new procedure in example 2, and the capillary electrophoresis effect graphs obtained are shown in fig. 5 and fig. 6, respectively. The result shows that the method disclosed by the invention can be used for rapidly and accurately detecting the sample with the high GGC repetition number.
The above embodiments are preferred embodiments of the present invention, but the present invention is not limited to the above embodiments, and any other changes, modifications, substitutions, combinations, and simplifications which do not depart from the spirit and principle of the present invention should be construed as equivalents thereof, and all such modifications are intended to be included in the scope of the present invention.
Sequence listing
<110> Suzhou university affiliated first hospital
<120> rapid sensitive detection method of NOTCH2NLC gene GGC repetitive sequence and application thereof
<160> 3
<170> SIPOSequenceListing 1.0
<210> 1
<211> 26
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
gcctgtgctt cggaccgtag cgccag 26
<210> 2
<211> 39
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
cgcacgctcc tgcacagcct ctcctccgcc gccgccgcc 39
<210> 3
<211> 21
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
cgcacgctcc tgcacagcct c 21
Claims (3)
1. A primer composition for detecting a GGC repetitive sequence of a NOTCH2NLC gene, which is characterized by comprising: the nucleotide sequence is shown as SEQ ID NO:1, and the nucleotide sequence of the upstream primer is shown as SEQ ID NO:2, the nucleotide sequence of the downstream primer is shown as SEQ ID NO:3, or a third primer shown in the figure.
2. An amplification reaction system for amplifying a GGC repeat sequence of a NOTCH2NLC gene, the amplification reaction system comprising the primer composition of claim 1.
3. A kit for rapidly detecting the GGC repeat sequence of a NOTCH2NLC gene, comprising the primer composition of claim 1 or the amplification reaction system of claim 2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110850961.1A CN113337587B (en) | 2021-07-27 | 2021-07-27 | Rapid sensitive detection method for NOTCH2NLC gene GGC repetitive sequence and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110850961.1A CN113337587B (en) | 2021-07-27 | 2021-07-27 | Rapid sensitive detection method for NOTCH2NLC gene GGC repetitive sequence and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113337587A CN113337587A (en) | 2021-09-03 |
CN113337587B true CN113337587B (en) | 2022-12-30 |
Family
ID=77480370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110850961.1A Active CN113337587B (en) | 2021-07-27 | 2021-07-27 | Rapid sensitive detection method for NOTCH2NLC gene GGC repetitive sequence and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113337587B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115029434B (en) * | 2022-07-22 | 2023-03-17 | 北京阅微基因技术股份有限公司 | NOTCH2NLC gene CGG repetition number detection system and kit |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110577987A (en) * | 2019-06-24 | 2019-12-17 | 胜亚生物科技(厦门)有限公司 | Detection method of CGG (glutamic acid G) repetitive sequence of FMR1 gene and application thereof |
CN112094893A (en) * | 2019-06-17 | 2020-12-18 | 杭州方夏生物科技有限公司 | Neuron endonucleosome disease NOTCH2NLC gene GGC repetitive amplification detection kit |
CN112553299A (en) * | 2019-09-10 | 2021-03-26 | 北京大学第一医院 | NOTCH2NLC gene GGC repetitive sequence amplification method |
-
2021
- 2021-07-27 CN CN202110850961.1A patent/CN113337587B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112094893A (en) * | 2019-06-17 | 2020-12-18 | 杭州方夏生物科技有限公司 | Neuron endonucleosome disease NOTCH2NLC gene GGC repetitive amplification detection kit |
CN110577987A (en) * | 2019-06-24 | 2019-12-17 | 胜亚生物科技(厦门)有限公司 | Detection method of CGG (glutamic acid G) repetitive sequence of FMR1 gene and application thereof |
CN112553299A (en) * | 2019-09-10 | 2021-03-26 | 北京大学第一医院 | NOTCH2NLC gene GGC repetitive sequence amplification method |
Also Published As
Publication number | Publication date |
---|---|
CN113337587A (en) | 2021-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | Single-cell brain organoid screening identifies developmental defects in autism | |
CN109055541B (en) | AD (Alzheimer's disease) -induced MCI (cardiac muscle dysfunction syndrome) diagnostic marker and application thereof | |
CN113337587B (en) | Rapid sensitive detection method for NOTCH2NLC gene GGC repetitive sequence and application thereof | |
CN109402132B (en) | Nucleic acid for coding SCN1A gene mutant and application thereof | |
CN110577987A (en) | Detection method of CGG (glutamic acid G) repetitive sequence of FMR1 gene and application thereof | |
Zhang et al. | Biological implications of genetic variations in autism spectrum disorders from genomics studies | |
CN115637288A (en) | Method for detecting copy number change of SMN1 and SMN2 genes and application thereof | |
CN110551812B (en) | CRISPR-Cas system for diagnosing spinal muscular atrophy and application thereof | |
CN110938685A (en) | Gene detection probe set for neonatal hereditary metabolic disease and hemoglobinopathy and application thereof | |
CN110511995B (en) | Tuberculosis markers and application thereof | |
CN115992212A (en) | UBE3A mutant protein, UBE3A gene mutant, amplification primer, detection reagent and application | |
CN115960997A (en) | Primer probe combination and kit for detecting exon14 skipping mutation of c-MET gene based on digital PCR platform | |
CN108531580A (en) | C5orf42 gene mutation bodies and its application | |
CN113186277B (en) | Marker of congenital megacolon and application thereof | |
CN114774549A (en) | Second-generation sequencing kit for targeted detection of CAH candidate gene | |
CN114032303A (en) | Oligonucleotide and method for detecting new mutation of gene ABCB11 | |
CN113355408A (en) | Molecular marker for detecting/curative effect evaluating early-onset schizophrenia and application thereof | |
CN113403383A (en) | Marker related to occurrence of congenital megacolon and application thereof | |
CN111378653A (en) | Primer, kit and method for detecting SCA gene mutation | |
CN108342404A (en) | INPP5E gene mutation bodies and its application | |
CN111378738A (en) | Detection primer, kit and method for HTT and JPH3 genes | |
CN110511992B (en) | TARDBP mutant gene, detection primer and kit | |
CN116218862B (en) | SELENOO gene mutant and application thereof | |
CN111690738B (en) | Reagent set and kit for detecting POU3F4 gene | |
CN108018351A (en) | The relevant biomarker of metabolic disease and its application caused by a kind of high lipid food with intake |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |